Clinical Trial Update: Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pembrolizumab with paclitaxel, carboplatin, and radiation therapy in stage II to IIIB non-small cell lung cancer has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Carboplatin (Paraplatin) (carboplatin)
• Paclitaxel (Taxol) (paclitaxel)
• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Stage II Non-Small Cell Lung Cancer, Stage IIIA Non-Small Cell Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2023-10-11